Cytokine Response to Abdominal Wall Reconstruction
Northwestern University · NCT07422584
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 25
- US sites recruiting
- 1
- Study start
- February 3, 2026
- Record last updated
- February 20, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a prospective, observational translational study of patients undergoing major abdominal wall reconstruction with primary fascial closure. The project integrates perioperative cytokine profiling, direct measurement of intra-abdominal pressure, and detailed clinical outcomes to define the biologic and physiologic consequences of high-tension closure.
The study includes three cohorts: 1) Healthy controls (N=5), 2) High-tension fascial closure AWR patients (N=10), 3) Low-tension fascial closure AWR patients (N=10). Fascial closure tension will not be altered for the purpose of the study and will be determined by the operating surgeon as part of routine clinical decision-making.
Being studied: Not applicable- observational study
Conditions: Incisional Ventral Hernia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Surgical Participants
- Adults aged 18 years or older
- Scheduled to undergo open retromuscular ventral hernia repair
- Able to provide written informed consent Healthy Control Participants
- Adults aged 18 years or older
- No known inflammatory, autoimmune, or immunologic disease
- Able to provide written informed consent
Exclusion Criteria
- Emergent or urgent cases
- Pregnancy
- Chronic systemic steroid use or immunosuppressive therapy
- Active infection at the time of enrollment
- Known autoimmune or inflammatory disease
- End-stage organ failure
- Abdominal surgery within the preceding 60 days
Recruiting US locations
Northwestern Memorial Hospital
Chicago, IL 60611
Site contact: Megan Melland-Smith, MD · 312-907-1414 · megan.mellandsmith@nm.org
Study contacts (from the official record)
- Megan Melland-Smith, MD · 312-907-1414 · megan.mellandsmith@nm.org
- Nancy Ly, MD · 262-455-1560 · nancy.ly@nm.org
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65